Sign in
You can sign in with one of these social accounts:
Search
Content
Industries
Ratings
Projects
Mind Brand
Mind on social media

Medicines

All storiesPublicationsNewsOpenmindVideo
Medicine
Cannabis in Ukraine: First reading of the bill – another step towards legalisation
Kristina Drogoziuk — 24 July 2023, 09:45
Medicine
What diseases threaten Ukrainians due to the explosion of the Kakhovka Hydroplant, and how to avoid them?
Kateryna Khutorna — 14 June 2023, 07:30
Medicine
"Without you all": Could there be a shortage of imported medicines in Ukraine?
Vitaliі Kravchenko — 23 November 2022, 14:00
War
Pharma at war: Reorientation from anti-COVID drugs to hemostatics, destroyed warehouses and migration of pharmacists
Kateryna Khutorna — 20 October 2022, 11:00
Medicine
Medicine at war: how the healthcare system has changed
Kateryna Khutorna — 17 August 2022, 10:00
Special Project

Billions against epidemic: how pharmaceutical world is weathering the crisis

And why pharmacists spare no money on innovation
Sergiy Kucherenko — 15 October 2020, 11:00
Medicine

Healthy growth: why pharma’s future lies with generics

Ukrainian pharmaceutical market will grow and stay popular among the investors in the next years. The generic drugs producers will win the most
Sergiy Kucherenko — 15 November 2019, 07:30
Society

Life Elixir: how a pharmaceutical company launched the production of infusions

And why is it unique for Ukraine.
Pavlo Harlamov, Viktor Gacenko — 10 May 2018, 12:30
Investments

Medical investment: where Ukrainian pharmacy needs support

What factors can attract foreign capital into the industry
Katerina Grebenik — 25 April 2018, 07:30
Investments

General director of pharmaceutical firm “Darnitsa”: “Import substitution is nothing more than another form of competition”

Svitlana Didenko speaks about market realities, public interests, patients’ preferences and the company’s readiness for the healthcare reform
5 April 2018, 09:45
© 2026 Mind, Future Media LLC